Roser Montañana-Rosell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roser Montañana-Rosell has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Ilary Allodi
Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark
9 shared publications - Raghavendra Selvan
University of Copenhagen, Copenhagen, Denmark
6 shared publications - Andreas Toft Soerensen
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
4 shared publications - Santiago Mora
Department of Neuroscience, University of Copenhagen, Blegdamsvej 3B Copenhagen 2200, Denmark; School of Psychology and Neuroscience, University of St Andrews, St Mary's Quad, South Street St Andrews KY16 9JP, UK
4 shared publications - Gith Noes-Holt
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
3 shared publications - Ole Kiehn
Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
3 shared publications
Latest Publications
- Open Access
- 30 December 2025
- Published by Elsevier in Neurobiology of Disease
- Vol. 219, 107253
Spinal circuit mechanisms constrain therapeutic windows for ALS intervention: A computational modeling study
- 30 December 2025
- Published by Elsevier in Neurobiology of Disease
- Vol. 219, 107253
Open AccessSpinal circuit mechanisms constrain therapeutic windows for ALS intervention: A computational modeling study
- Open Access
Spinal Circuit Mechanisms Constrain Therapeutic Windows for ALS Intervention
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive breakdown of neural circuits which leads to motoneuron death. Earlier work from our lab showed that dysregulation of inhibitory V1 interneurons precedes the degeneration of excitatory V2a interneurons and motoneurons and that stabilizing V1–motoneuron connections improved motor function and saved motoneurons in the SOD1 G93A ALS mouse model. However, the optimal timing for this intervention remains unclear. To address this, we developed a spiking neural network model of spinal locomotor circuits to simulate healthy and ALS-like conditions. By modeling changes in network connectivity and synaptic dynamics, we predict that V1 dysregulation induces hyperexcitation in motoneurons which is preferentially observed in flexor motoneurons leading to the disruption of flexor-extensor coordination, and potentially contributing to selective vulnerability of flexor motoneurons. Stabilizing V1 synapses preserved motor output even after motoneuron loss, suggesting that therapeutic benefit is possible into symptomatic stages. However, model predictions also highlighted that after sustained synaptic loss and the development of slower synaptic dynamics within the network, synaptic stabilization leads to maladaptive extensor-biased activity, suggesting that excitatory/inhibitory balance impacts treatment effectiveness. Finally, the model indicated that V1 stabilization could lead to rescue of the V2a excitatory interneurons, a finding that we were able to confirm experimentally in the SOD1 G93A ALS mouse model. By exploring different scenarios of synaptic loss and cell dysregulation during synaptic stabilization, our models provide a framework for predicting candidate time windows for spinal circuit interventions, which may guide future preclinical investigations.
Open AccessSpinal Circuit Mechanisms Constrain Therapeutic Windows for ALS Intervention
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive breakdown of neural circuits which leads to motoneuron death. Earlier work from our lab showed that dysregulation of inhibitory V1 interneurons precedes the degeneration of excitatory V2a interneurons and motoneurons and that stabilizing V1–motoneuron connections improved motor function and saved motoneurons in the SOD1 G93A ALS mouse model. However, the optimal timing for this intervention remains unclear. To address this, we developed a spiking neural network model of spinal locomotor circuits to simulate healthy and ALS-like conditions. By modeling changes in network connectivity and synaptic dynamics, we predict that V1 dysregulation induces hyperexcitation in motoneurons which is preferentially observed in flexor motoneurons leading to the disruption of flexor-extensor coordination, and potentially contributing to selective vulnerability of flexor motoneurons. Stabilizing V1 synapses preserved motor output even after motoneuron loss, suggesting that therapeutic benefit is possible into symptomatic stages. However, model predictions also highlighted that after sustained synaptic loss and the development of slower synaptic dynamics within the network, synaptic stabilization leads to maladaptive extensor-biased activity, suggesting that excitatory/inhibitory balance impacts treatment effectiveness. Finally, the model indicated that V1 stabilization could lead to rescue of the V2a excitatory interneurons, a finding that we were able to confirm experimentally in the SOD1 G93A ALS mouse model. By exploring different scenarios of synaptic loss and cell dysregulation during synaptic stabilization, our models provide a framework for predicting candidate time windows for spinal circuit interventions, which may guide future preclinical investigations.
- Open Access
- 7 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Stabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS
Loss of connectivity between spinal V1 inhibitory interneurons and motor neurons is found early in disease in the SOD1G93A mice. Such changes in premotor inputs can contribute to homeostatic imbalance of motor neurons. Here, we show that the Extended Synaptotagmin 1 (Esyt1) presynaptic organizer is downregulated in V1 interneurons. V1 restricted overexpression of Esyt1 rescues inhibitory synapses, increases motor neuron survival, and ameliorates motor phenotypes. Two gene therapy approaches overexpressing ESYT1 were investigated; one for local intraspinal delivery, and the other for systemic administration using an AAV-PHP.eB vector delivered intravenously. Improvement of motor functions is observed in both approaches, however systemic administration appears to significantly reduce onset of motor impairment in the SOD1G93A mice in absence of side effects. Altogether, we show that stabilization of V1 synapses by ESYT1 overexpression has the potential to improve motor functions in ALS, demonstrating that interneurons can be a target to attenuate ALS symptoms.
- 7 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessStabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS
Loss of connectivity between spinal V1 inhibitory interneurons and motor neurons is found early in disease in the SOD1G93A mice. Such changes in premotor inputs can contribute to homeostatic imbalance of motor neurons. Here, we show that the Extended Synaptotagmin 1 (Esyt1) presynaptic organizer is downregulated in V1 interneurons. V1 restricted overexpression of Esyt1 rescues inhibitory synapses, increases motor neuron survival, and ameliorates motor phenotypes. Two gene therapy approaches overexpressing ESYT1 were investigated; one for local intraspinal delivery, and the other for systemic administration using an AAV-PHP.eB vector delivered intravenously. Improvement of motor functions is observed in both approaches, however systemic administration appears to significantly reduce onset of motor impairment in the SOD1G93A mice in absence of side effects. Altogether, we show that stabilization of V1 synapses by ESYT1 overexpression has the potential to improve motor functions in ALS, demonstrating that interneurons can be a target to attenuate ALS symptoms.
- Open Access
- 31 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (22) , eadk3229
Spinal inhibitory neurons degenerate before motor neurons and excitatory neurons in a mouse model of ALS
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of somatic motor neurons. A major focus has been directed to motor neuron intrinsic properties as a cause for degeneration, while less attention has been given to the contribution of spinal interneurons. In the present work, we applied multiplexing detection of transcripts and machine learning–based image analysis to investigate the fate of multiple spinal interneuron populations during ALS progression in the SOD1 G93A mouse model. The analysis showed that spinal inhibitory interneurons are affected early in the disease, before motor neuron death, and are characterized by a slow progressive degeneration, while excitatory interneurons are affected later with a steep progression. Moreover, we report differential vulnerability within inhibitory and excitatory subpopulations. Our study reveals a strong interneuron involvement in ALS development with interneuron specific degeneration. These observations point to differential involvement of diverse spinal neuronal circuits that eventually may be determining motor neuron degeneration.
- 31 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (22) , eadk3229
Open AccessSpinal inhibitory neurons degenerate before motor neurons and excitatory neurons in a mouse model of ALS
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of somatic motor neurons. A major focus has been directed to motor neuron intrinsic properties as a cause for degeneration, while less attention has been given to the contribution of spinal interneurons. In the present work, we applied multiplexing detection of transcripts and machine learning–based image analysis to investigate the fate of multiple spinal interneuron populations during ALS progression in the SOD1 G93A mouse model. The analysis showed that spinal inhibitory interneurons are affected early in the disease, before motor neuron death, and are characterized by a slow progressive degeneration, while excitatory interneurons are affected later with a steep progression. Moreover, we report differential vulnerability within inhibitory and excitatory subpopulations. Our study reveals a strong interneuron involvement in ALS development with interneuron specific degeneration. These observations point to differential involvement of diverse spinal neuronal circuits that eventually may be determining motor neuron degeneration.
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S612-S613
STABILIZATION OF V1 INTERNEURON-MOTOR NEURON SYNAPSES AMELIORATES MOTOR DEFICITS IN A MOUSE MODEL OF ALS
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S612-S613
Open AccessSTABILIZATION OF V1 INTERNEURON-MOTOR NEURON SYNAPSES AMELIORATES MOTOR DEFICITS IN A MOUSE MODEL OF ALS
- Open Access
Spinal inhibitory neurons degenerate before motor neurons and excitatory neurons in a mouse model of ALS
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of somatic motor neurons. Major focus has been directed to motor neuron intrinsic properties as a cause for degeneration while less attention has been given to the contribution of spinal interneurons. In the present work, we applied multiplexing detection of transcripts and machine learning-based image analysis to investigate the fate of multiple spinal interneuron populations during ALS progression in the SOD1 G93A mouse model. The analysis showed that spinal inhibitory interneurons are affected early in disease, before motor neurons death, and are characterized by a slow progressive degeneration, while excitatory interneurons are affected later with a steep progression. Moreover, we report differential vulnerability within inhibitory and excitatory subpopulations, with interneurons directly projecting onto motor neurons being preferentially affected. Our study reveals a strong interneuron involvement in ALS development with interneuron specific degeneration. This points to differential involvement of diverse spinal neuronal circuits that eventually may be determining for motor neuron degeneration. Teaser: A new approach to study the motor neuron disorder Amyotrophic Lateral Sclerosis shows the early and differential dysregulation of spinal interneurons.
Open AccessSpinal inhibitory neurons degenerate before motor neurons and excitatory neurons in a mouse model of ALS
Amyotrophic lateral sclerosis (ALS) is characterized by the progressive loss of somatic motor neurons. Major focus has been directed to motor neuron intrinsic properties as a cause for degeneration while less attention has been given to the contribution of spinal interneurons. In the present work, we applied multiplexing detection of transcripts and machine learning-based image analysis to investigate the fate of multiple spinal interneuron populations during ALS progression in the SOD1 G93A mouse model. The analysis showed that spinal inhibitory interneurons are affected early in disease, before motor neurons death, and are characterized by a slow progressive degeneration, while excitatory interneurons are affected later with a steep progression. Moreover, we report differential vulnerability within inhibitory and excitatory subpopulations, with interneurons directly projecting onto motor neurons being preferentially affected. Our study reveals a strong interneuron involvement in ALS development with interneuron specific degeneration. This points to differential involvement of diverse spinal neuronal circuits that eventually may be determining for motor neuron degeneration. Teaser: A new approach to study the motor neuron disorder Amyotrophic Lateral Sclerosis shows the early and differential dysregulation of spinal interneurons.
- Open Access
- 7 March 2023
- Published by Springer Nature in Research Square
Stabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS
Loss of connectivity between spinal V1 inhibitory interneurons and motor neurons is found early in disease in the SOD1G93A mice. Such changes in premotor inputs can contribute to homeostatic imbalance of vulnerable motor neurons. Here, we show, for the first time, that stabilization of V1 synapses by overexpression of a presynaptic organizer, increases motor neuron survival and ameliorates motor phenotype, demonstrating that interneurons can be a potential target to attenuate ALS symptoms.
- 7 March 2023
- Published by Springer Nature in Research Square
Open AccessStabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS
Loss of connectivity between spinal V1 inhibitory interneurons and motor neurons is found early in disease in the SOD1G93A mice. Such changes in premotor inputs can contribute to homeostatic imbalance of vulnerable motor neurons. Here, we show, for the first time, that stabilization of V1 synapses by overexpression of a presynaptic organizer, increases motor neuron survival and ameliorates motor phenotype, demonstrating that interneurons can be a potential target to attenuate ALS symptoms.
- Open Access
Stabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS
Loss of connectivity between spinal V1 inhibitory inter-neurons and motor neurons is found early in disease in the SOD1 G93A ALS mice. Such changes in premotor inputs can contribute to homeostatic imbalance of vulnerable motor neurons. Here, we show, for the first time, that stabilization of V1 synapses by overexpression of the Extended Synap-totagmin 1 presynaptic organizer increases motor neuron survival and ameliorates motor phenotypes, demonstrating that interneurons can be a potential target to attenuate ALS symptoms.
Open AccessStabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS
Loss of connectivity between spinal V1 inhibitory inter-neurons and motor neurons is found early in disease in the SOD1 G93A ALS mice. Such changes in premotor inputs can contribute to homeostatic imbalance of vulnerable motor neurons. Here, we show, for the first time, that stabilization of V1 synapses by overexpression of the Extended Synap-totagmin 1 presynaptic organizer increases motor neuron survival and ameliorates motor phenotypes, demonstrating that interneurons can be a potential target to attenuate ALS symptoms.
- Open Access
- 31 May 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons
ALS is characterized by progressive inability to execute movements. Motor neurons innervating fast-twitch muscle-fibers preferentially degenerate. The reason for this differential vulnerability and its consequences on motor output is not known. Here, we uncover that fast motor neurons receive stronger inhibitory synaptic inputs than slow motor neurons, and disease progression in the SOD1G93A mouse model leads to specific loss of inhibitory synapses onto fast motor neurons. Inhibitory V1 interneurons show similar innervation pattern and loss of synapses. Moreover, from postnatal day 63, there is a loss of V1 interneurons in the SOD1G93A mouse. The V1 interneuron degeneration appears before motor neuron death and is paralleled by the development of a specific locomotor deficit affecting speed and limb coordination. This distinct ALS-induced locomotor deficit is phenocopied in wild-type mice but not in SOD1G93A mice after appearing of the locomotor phenotype when V1 spinal interneurons are silenced. Our study identifies a potential source of non-autonomous motor neuronal vulnerability in ALS and links ALS-induced changes in locomotor phenotype to inhibitory V1-interneurons.
- 31 May 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Open AccessLocomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons
ALS is characterized by progressive inability to execute movements. Motor neurons innervating fast-twitch muscle-fibers preferentially degenerate. The reason for this differential vulnerability and its consequences on motor output is not known. Here, we uncover that fast motor neurons receive stronger inhibitory synaptic inputs than slow motor neurons, and disease progression in the SOD1G93A mouse model leads to specific loss of inhibitory synapses onto fast motor neurons. Inhibitory V1 interneurons show similar innervation pattern and loss of synapses. Moreover, from postnatal day 63, there is a loss of V1 interneurons in the SOD1G93A mouse. The V1 interneuron degeneration appears before motor neuron death and is paralleled by the development of a specific locomotor deficit affecting speed and limb coordination. This distinct ALS-induced locomotor deficit is phenocopied in wild-type mice but not in SOD1G93A mice after appearing of the locomotor phenotype when V1 spinal interneurons are silenced. Our study identifies a potential source of non-autonomous motor neuronal vulnerability in ALS and links ALS-induced changes in locomotor phenotype to inhibitory V1-interneurons.
- 9 July 2019
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 26 (10) , 1187-1196
Angiotensin AT2 receptor–induced interleukin-10 attenuates neuromyelitis optica spectrum disorder–like pathology
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing inflammatory central nervous system (CNS) disease for which there is no cure. Immunoglobulin G autoantibodies specific for the water channel aquaporin-4 are a serum biomarker, believed to induce complement-dependent astrocyte damage with secondary demyelination. Objective: To investigate the effect of angiotensin AT2 receptor (AT2R) stimulation on NMOSD-like pathology and its underlying mechanism. Methods: NMOSD-like pathology was induced in mice by intracerebral injection of immunoglobulin-G isolated from NMOSD patient serum, with complement. This mouse model produces the characteristic histological features of NMOSD. A specific AT2R agonist, Compound 21 (C21), was given intracerebrally at day 0 and by intrathecal injection at day 2. Results: Loss of aquaporin-4 and glial fibrillary acidic protein was attenuated by treatment with C21. Administration of C21 induced mRNA for interleukin-10 in the brain. NMOSD-like pathology was exacerbated in interleukin-10-deficient mice, suggesting a protective role. C21 treatment did not attenuate NMOSD-like pathology in interleukin-10-deficient mice, indicating that the protective effect of AT2R stimulation was dependent on interleukin-10. Conclusion: Our findings identify AT2R as a novel potential therapeutic target for the treatment of NMOSD. Interleukin-10 signaling is an essential part of the protective mechanism counteracting NMOSD pathology.
- 9 July 2019
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 26 (10) , 1187-1196
Angiotensin AT2 receptor–induced interleukin-10 attenuates neuromyelitis optica spectrum disorder–like pathology
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing inflammatory central nervous system (CNS) disease for which there is no cure. Immunoglobulin G autoantibodies specific for the water channel aquaporin-4 are a serum biomarker, believed to induce complement-dependent astrocyte damage with secondary demyelination. Objective: To investigate the effect of angiotensin AT2 receptor (AT2R) stimulation on NMOSD-like pathology and its underlying mechanism. Methods: NMOSD-like pathology was induced in mice by intracerebral injection of immunoglobulin-G isolated from NMOSD patient serum, with complement. This mouse model produces the characteristic histological features of NMOSD. A specific AT2R agonist, Compound 21 (C21), was given intracerebrally at day 0 and by intrathecal injection at day 2. Results: Loss of aquaporin-4 and glial fibrillary acidic protein was attenuated by treatment with C21. Administration of C21 induced mRNA for interleukin-10 in the brain. NMOSD-like pathology was exacerbated in interleukin-10-deficient mice, suggesting a protective role. C21 treatment did not attenuate NMOSD-like pathology in interleukin-10-deficient mice, indicating that the protective effect of AT2R stimulation was dependent on interleukin-10. Conclusion: Our findings identify AT2R as a novel potential therapeutic target for the treatment of NMOSD. Interleukin-10 signaling is an essential part of the protective mechanism counteracting NMOSD pathology.